Creavo celebrates 5-year anniversary

Creavo celebrates 5-year anniversary

Creavo celebrates 5-year anniversary By Steve Parker, Chief Executive Officer This week marks five years since Creavo was formed – and another milestone as we celebrate Creavo entering an exciting and pivotal phase in its journey. We are now in the final stages of...
Creavo poised for growth

Creavo poised for growth

Coventry medtech company expands into new office as it prepares for further growth. The move marks five years since Creavo was formed. Coventry-based medtech company Creavo Medical Technologies (Creavo), has moved to a new site in the city to enable it to grow...
Article for US Healthcare Publication

Article for US Healthcare Publication

Portable MCG technology could transform the treatment of heart disease across the US Frank Peacock, MD, FACEP, FACC Professor, Associate Chair, and Research Director at Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine. American Heart Month...
Acute Cardiovascular Care 2019

Acute Cardiovascular Care 2019

Creavo will be at the Acute Cardiovascular Care Conference 2019 in Malaga this weekend. You’ll find us on stand B1 ready to discuss how our portable MCG device Corsens® could act as an aid for physicians in ruling out patients with acute, active ischemia in busy...
National Technology Awards – Shortlisting

National Technology Awards – Shortlisting

Creavo is delighted to announce it has been shortlisted for the Healthcare Technology of the Year award at the 2019 National Technology Awards. The National Technology Awards are the most comprehensive celebration of technology of the year, organised by National...
The tell-tale heart – Health Investor

The tell-tale heart – Health Investor

In a wide-ranging interview featured in the latest edition of HealthInvestor (February 2019), our chairman Robert Barr discusses Creavo’s MCG device Corsens, and shares our ambitious plans for commercialisation and the potential for further device applications. Robert...